微信公众号
证券之星APP
| 报告期 | 净资产收益率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2024-09-30 | 2.32% | -23.18% | 179.52% | 84/129 | 4.79% | 迈瑞医疗 | 28.68% | 行业排名> |
| 2024-06-30 | 0.83% | -26.55% | 31.75% | 87/129 | 3.05% | 迈瑞医疗 | 20.2% | 行业排名> |
| 2024-03-31 | 0.63% | 0% | -77.74% | 85/129 | 1.68% | 迈瑞医疗 | 9.12% | 行业排名> |
| 2023-12-31 | 2.83% | -16.27% | -6.29% | 82/129 | 5.06% | 迈瑞医疗 | 33.21% | 行业排名> |
| 2023-09-30 | 3.02% | -16.11% | 167.26% | 85/129 | 5.79% | 迈瑞医疗 | 28.34% | 行业排名> |
| 2023-06-30 | 1.13% | -56.7% | 79.37% | 94/129 | 3.8% | 迈瑞医疗 | 18.36% | 行业排名> |
| 2023-03-31 | 0.63% | -61.11% | -81.36% | 96/129 | 2.29% | 安杰思 | 8.56% | 行业排名> |
| 2022-12-31 | 3.38% | -36.59% | -6.11% | 97/129 | 13.44% | 九安医疗 | 146.56% | 行业排名> |
| 2022-09-30 | 3.6% | -42.77% | 37.93% | 94/129 | 12.77% | 九安医疗 | 140.94% | 行业排名> |
| 2022-06-30 | 2.61% | -30.03% | 61.11% | 88/129 | 9.3% | 九安医疗 | 142.25% | 行业排名> |
| 2022-03-31 | 1.62% | -28.32% | -69.61% | 74/129 | 6.26% | 九安医疗 | 142.71% | 行业排名> |
| 2021-12-31 | 5.33% | -47.33% | -15.26% | 106/129 | 17.49% | 热景生物 | 121.78% | 行业排名> |
| 2021-09-30 | 6.29% | -49.8% | 68.63% | 86/129 | 15.94% | 热景生物 | 99.69% | 行业排名> |
| 2021-06-30 | 3.73% | -44.99% | 65.04% | 95/129 | 11.54% | 热景生物 | 99.09% | 行业排名> |
| 2021-03-31 | 2.26% | 10.78% | -77.67% | 68/129 | 6.23% | 热景生物 | 57.63% | 行业排名> |
| 2020-12-31 | 10.12% | -39.29% | -19.23% | 89/129 | 25.82% | 中红医疗 | 168% | 行业排名> |
| 2020-09-30 | 12.53% | 30.93% | 84.81% | 48/129 | 19.85% | 圣湘生物 | 112.46% | 行业排名> |
| 2020-06-30 | 6.78% | -11.26% | 232.35% | 60/129 | 15.16% | 博拓生物 | 108.13% | 行业排名> |
| 2020-03-31 | 2.04% | 2% | -87.76% | 39/129 | 3.4% | 圣湘生物 | 29.33% | 行业排名> |
| 2019-12-31 | 16.67% | 7% | 118.19% | 50/129 | 14.38% | 健尔康 | 84.09% | 行业排名> |
| 2019-06-30 | 7.64% | 2% | -50.96% | 25/129 | 6.73% | 祥生医疗 | 28.56% | 行业排名> |
| 2018-12-31 | 15.58% | 14.9% | 14.9% | 52/129 | 12.98% | 心脉医疗 | 31.04% | 行业排名> |
| 2017-12-31 | 13.56% | 2.57% | 2.57% | 50/129 | 13.82% | 新华医疗 | 13.55% | 行业排名> |
| 2016-12-31 | 13.22% | -24.84% | 38.14% | 44/129 | 16.21% | 安旭生物 | 48.71% | 行业排名> |